Novo Nordisk's Wegovy weight loss drug approved in China

Novo Nordisk said Tuesday that its Wegovy weight loss treatment has been approved in China for long-term weight management, opening up the blockbuster drug for sale in the world's second largest economy.China's National Medical Products Administration "recently" approved the weekly injectable drug, Novo Nordisk said in a press release on the Chinese version of its website, according to Google translate.The drug will initially be available to patients with a body mass index (BMI) of 30kg/m2 — the threshold f ...